What Tirzepatide Is: Dual-Incretin Agonism

Aug 01, 2025 Leave a message

Tirzepatide is not a single peptide hormone, but a synthetic, single-chain 39-amino acid peptide engineered to function as a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. This is its defining feature and differentiator from earlier GLP-1-only agonists like Semaglutide.

●Mechanism Nuance: Tirzepatide doesn't merely activate both receptors equally; research suggests it has a higher affinity for the GIP receptor than the GLP-1 receptor. The synergistic effect of co-activating these pathways appears responsible for its superior efficacy in weight loss and glycemic control compared to selective GLP-1 agonists in clinical trials. GIP receptor activation may potentiate the effects of GLP-1, particularly on appetite suppression and possibly fat metabolism.

glp-1-bodybuilding-featured

Send Inquiry

whatsapp

Phone

E-mail

Inquiry